Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2Lymphoid 2Classical hematology 2

Conditions

Leukemia, Myeloid, Acute 103Precursor Cell Lymphoblastic Leukemia-Lymphoma 93Myelodysplastic Syndromes 89Leukemia 79Lymphoma 71Lymphoma, Non-Hodgkin 70Leukemia, Lymphocytic, Chronic, B-Cell 65Hodgkin Disease 55Multiple Myeloma 49Lymphoma, Mantle-Cell 42Lymphoma, Follicular 41Burkitt Lymphoma 39Lymphoma, Large B-Cell, Diffuse 38Lymphoma, B-Cell, Marginal Zone 36Lymphoma, Large-Cell, Immunoblastic 33Myeloproliferative Disorders 32Hematologic Neoplasms 32Leukemia, Myelogenous, Chronic, BCR-ABL Positive 30Neoplasms, Plasma Cell 27Leukemia, Myeloid, Accelerated Phase 25Leukemia, Myeloid, Chronic-Phase 24Congenital Abnormalities 24Leukemia, Myelomonocytic, Chronic 23Graft vs Host Disease 22Dendritic Cell Sarcoma, Interdigitating 21Recurrence 20Anemia, Refractory, with Excess of Blasts 20Waldenstrom Macroglobulinemia 18Blast Crisis 18Primary Myelofibrosis 17

Interventions

fludarabine phosphate 5fludarabine 5Cyclophosphamide 5Whole-Body Irradiation 4Busulfan 3Antilymphocyte Serum 3Thiotepa 2Mycophenolic Acid 2Melphalan 2Alemtuzumab 2posaconazole 1eltrombopag 1Therapeutics 1Tacrolimus 1Specimen Handling 1Sirolimus 1Peripheral Blood Stem Cell Transplantation 1Passive Cutaneous Anaphylaxis 1Morphine 1Methylprednisolone Hemisuccinate 1Methylprednisolone 1Methadone 1Hydromorphone 1Genetic Counseling 1Erythrocyte Transfusion 1Cyclosporins 1Clofarabine 1Clinical Trials, Phase I as Topic 1Bone Marrow Transplantation 1Blood Transfusion 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Bone Marrow Failure Disorders × Melphalan × Other hematologic neoplasm × Clear all
NCT02061800 2024-06-04

CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

Columbia University

Phase 1/2 Active not recruiting
14 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Neutropenia, Severe Congenital, Autosomal Recessive 3, Bone Marrow Failure Disorders, Shwachman-Diamond Syndrome, Primary Immunodeficiency Diseases, Acquired Immunodeficiency Syndrome, Anemia, Aplastic, Anemia, Sickle Cell, Hemoglobinopathies, Histiocytosis, Langerhans-Cell, Lymphoma, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Histiocytosis, Anemia, Diamond-Blackfan, Lymphohistiocytosis, Hemophagocytic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile, Macrophage Activation Syndrome

NCT01049854 2018-08-21

CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant

New York Medical College

Phase 2 Completed
20 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Sickle Cell, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Metabolism, Inborn Errors, Histiocytosis, beta-Thalassemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡